Nominations phase for the first European Paulskirche Prize begins on 1 September

29.8.2025 09:15:00 CEST | news aktuell GmbH | Press Release

Share

Frankfurt. Democracy needs role models – especially in times of growing challenges. Therefore, the European Paulskirche Prize for Democracy, which will be awarded for the first time in Frankfurt am Main, is intended to make the commitment of those who defend freedom, the rule of law and a united Europe with courage and determination visible. On 28 August Lord Mayor Mike Josef, City Council President Hilime Arslaner and Mayor Nargess Eskandari-Grünberg briefed the attendees at the Paulskirche about this prize and the phase that commences on 1 September.

The European Paulskirche Prize for Democracy will be awarded for the first time in May 2026 at the Paulskirche. It is endowed with 50,000 euros and is to be awarded every two years in future. Individuals, organisations, civic groups and associations or institutions that commit themselves to democracy, freedom and the rule of law in an outstanding manner and that promote the inclusion of all in a varied and diverse democracy may be nominated. Nominations may be submitted from 1 September until 30 November via an online form in German, English and French: frankfurt.de/paulskirchenpreis.

With the prize the events of 1848/1849 are to be remembered. At that time the first elected German parliament, the National Assembly, met at the Paulskirche and thus laid the foundation for democracy and the rule of law in Germany. The delegates had rebelled against the principalities and fought for freedom, human rights, and equality for all. Many ideas, such as the fundamental rights that were adopted at the Paulskirche, were later incorporated into the constitution of the Federal Republic of Germany.

Prize winners will be decided on by a jury comprising 12 members: Lord Mayor Mike Josef, City Council President Hilime Arslaner, Mayor Nargess Eskandari-Grünberg, Head of Culture and Science Ina Hartwig, Julia Klöckner, President of the German Federal Parliament, Astrid Wallmann, President of the Hessian State Parliament, the sociologist and publicist Prof. Dr. Ulrike Ackermann, the peace and conflict researcher Prof. Dr. Nicole Deitelhoff, the musician and peace activist Sebastian Krumbiegel, the author and human rights activist Düzen Tekkal, the historian Prof. Dr. Michael Wolffsohn as well as the lawyer and former President of the German Federal Constitutional Court Prof. Dr. Dr. h.c. mult. Andreas Voßkuhle.

Contacts

Presse und Information Office of the City of Frankfurt am Main
E-Mail: presse.info@stadt-frankfurt.de

Images

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:28:38 CEST | Press Release

New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found. The report, “The Governance Performance of the Fifty States: The U.S. Berggruen Governance Index”, applies the research team’s “governance triangle” from past global country rankings to the 50 US states. The report has now been presented to the public at Columbia University in New York. “Unlike in the Berggruen Governance Index’s cross-national comparisons, where the three dimensions are broadly correlated, in the 50 U.S. states they often run counter to each other,” the authors conclude. “This may seem counterintuitive, as one might expect a well-governed state to finish high on all three and a poor

Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release

Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye